Lecturer in Biochemistry, Sheffield Hallam University
Daniel Kelly is a lecturer in Biochemistry at Sheffield Hallam University with research interests in cardiovascular disease, type 2 diabetes, obesity and the role of testosterone in these diseases. Following his PhD studying the anti-inflammatory effects of testosterone on atherosclerosis, Daniel undertook a postdoc at the University of Sheffield to work with Professor Hugh Jones to investigate the tissue-specific actions of testosterone related to the pathogenesis of type 2 diabetes and cardiovascular disease. This research continues at Sheffield Hallam University and extends through on-going collaborations with partners at the University of Sheffield, University of Chile, Barnsley NHS foundation trust and Bayer Healthcare where he is currently using cell culture systems, pre-clinical models and medical trials of replacement therapy to uncover the underlying mechanisms of testosterone action. He has published in several high-impact journals in the field of endocrinology and acts as a reviewer for many of these journals more.
Daniel has an honorary lectureship position at the University of Sheffield allowing close collaboration across the Sheffield Universities. He is the deputy course leader for the undergraduate Biomedical Science degree at Sheffield Hallam University where he uses his current and prior research to inform his teaching in areas related to metabolism, endocrinology, cell biology, and biological basis of disease.
Low testosterone in men associated with an early death – new study
May 15, 2024 07:51 am UTC| Health
It has long been thought that testosterone shortens mens lives. Studies in neutered animals and Korean eunuchs seem to confirm this. However, a new study, published in the Annals of Internal Medicine, draws these findings...
Does ejaculating often reduce your risk of prostate cancer?
Apr 24, 2024 09:34 am UTC| Health
In terms of mens health issues, prostate cancer features high on the agenda. Its the second most diagnosed cancer in men globally closely followed by lung cancer. And its the most common cancer in men in the UK. As the...
Caster Semenya: how much testosterone is too much for a female athlete?
May 02, 2019 16:46 pm UTC| Sports
The South African athlete, Caster Semenya, has lost her case against the athletic governing body, IAAF, which means that she will have to take medication to lower her testosterone levels if she wishes to continue competing...
South African telescope discovers a giant galaxy that’s 32 times bigger than Earth’s